218 related articles for article (PubMed ID: 2415145)
1. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
Ferguson A; Moore M; Fox H
Br J Cancer; 1985 Oct; 52(4):551-63. PubMed ID: 2415145
[TBL] [Abstract][Full Text] [Related]
2. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.
Csiba A; Whitwell HL; Moore M
Br J Cancer; 1984 Nov; 50(5):699-709. PubMed ID: 6238615
[TBL] [Abstract][Full Text] [Related]
3. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
Whitwell HL; Hughes HP; Moore M; Ahmed A
Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
[TBL] [Abstract][Full Text] [Related]
4. An investigation of NCRC11 immunoreactivity in normal and neoplastic epithelia of the female genital tract and ovary.
Hitchcock A; Ellis IO; Bell J; Robins A
Histopathology; 1989 Aug; 15(2):187-94. PubMed ID: 2777219
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
[TBL] [Abstract][Full Text] [Related]
6. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
[TBL] [Abstract][Full Text] [Related]
7. Expression of MAM-3 and MAM-6 antigens in endometrial and endocervical adenocarcinomas.
Tsubura A; Morii S; Hilkens J; Hilgers J
Virchows Arch A Pathol Anat Histopathol; 1985; 407(1):59-67. PubMed ID: 3925626
[TBL] [Abstract][Full Text] [Related]
8. The expression of CEA, CA 19-9 and HMFG antigens in ovarian clear-cell and endometrioid carcinomas.
Helle M; Helin H; Ashorn P; Putkinen EL; Krohn K; Wahlström T
Pathol Res Pract; 1992 Feb; 188(1-2):74-7. PubMed ID: 1594502
[TBL] [Abstract][Full Text] [Related]
9. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of colon-ovarian tumor antigen and colon-specific antigen in gynecologic tumors.
Ueda G; Shimizu C; Saito J; Tanaka Y; Inoue M; Tanizawa O
Gynecol Oncol; 1989 Oct; 35(1):90-2. PubMed ID: 2792910
[TBL] [Abstract][Full Text] [Related]
11. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ; Cordon-Cardo C; Lewis JL; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):568-72. PubMed ID: 6582512
[TBL] [Abstract][Full Text] [Related]
12. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
[TBL] [Abstract][Full Text] [Related]
13. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
14. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
Bhattacharya M; Barlow JJ
Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
[No Abstract] [Full Text] [Related]
15. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.
Hilders CG; Houbiers JG; Krul EJ; Fleuren GJ
Am J Clin Pathol; 1994 Jan; 101(1):5-12. PubMed ID: 7506480
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
Rowe DJ; Beverley PC
Br J Cancer; 1984 Feb; 49(2):149-59. PubMed ID: 6365132
[TBL] [Abstract][Full Text] [Related]
17. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated antigens in gynecologic cancer.
DiSaia PJ
Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
[TBL] [Abstract][Full Text] [Related]
19. Expression of major histocompatibility complex class I antigens in normal and transformed rat thyroid epithelial cell lines.
Fontana S; Del Vecchio L; Racioppi L; Carbone E; Pinto A; Colletta G; Zappacosta S
Cancer Res; 1987 Aug; 47(15):4178-83. PubMed ID: 3607759
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens.
Boerman OC; van Niekerk CC; Makkink K; Hanselaar TG; Kenemans P; Poels LG
Int J Gynecol Pathol; 1991; 10(1):15-25. PubMed ID: 2007534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
